IN THIS JANUARY 2025 ISSUE -
In the fourth quarter of 2024, US antitrust regulators continued their rigorous scrutiny of mergers and acquisitions. The US Department of Justice (DOJ), under the leadership of the outgoing Biden administration, and several state attorneys general filed a lawsuit to block UnitedHealth Group Inc.’s $3.3 billion acquisition of Amedisys Inc., citing concerns over competition in home health and hospice services as well as nurse employment. However, President Donald Trump’s appointments to lead the antitrust agencies, including Gail Slater for the DOJ’s Antitrust Division, signal a more predictable and business-friendly approach compared to the previous administration.
In Europe, the European Commission (EC) upheld its approach in merger control cases, as demonstrated by the Court of Justice of the European Union’s (CJEU) affirmation of the EC’s decision to prohibit the Thyssenkrupp-Tata Steel joint venture. The EC also assessed Nvidia’s acquisition of Run:ai under Article 22 of the EU Merger Regulation, ultimately clearing the transaction unconditionally. In the UK, the Competition and Markets Authority (CMA) emphasized the importance of proportionality in merger examinations and explored mechanisms to secure rivalry-enhancing efficiencies.
Below we provide more detail on these developments, among other notable M&A events that occurred during the final quarter of 2024.
Please see full publication below for more information.
